Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-25 @ 9:24 PM
Study NCT ID:
NCT01653756
Status:
COMPLETED
Last Update Posted:
2021-03-17
First Post:
2012-07-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects
Sponsor:
SecuraBio
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IPI-145-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None